These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38899443)

  • 1. Ultrasensitive quantification of PD-L1+ extracellular vesicles in melanoma patient plasma using a parallelized high throughput droplet digital assay.
    Shen H; Atiyas Y; Yang Z; Lin AA; Yang J; Liu D; Park J; Guo W; Issadore DA
    Lab Chip; 2024 Jul; 24(14):3403-3411. PubMed ID: 38899443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma.
    Serratì S; Guida M; Di Fonte R; De Summa S; Strippoli S; Iacobazzi RM; Quarta A; De Risi I; Guida G; Paradiso A; Porcelli L; Azzariti A
    Mol Cancer; 2022 Jan; 21(1):20. PubMed ID: 35042524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized Imaging of Programmed Death-Ligand 1 on Individual Tumor-Derived Extracellular Vesicles for Prediction of Immunotherapy Response.
    Zhang J; Guan M; Lv M; Liu Y; Zhang H; Zhang Z; Zhang K
    ACS Nano; 2023 Oct; 17(20):20120-20134. PubMed ID: 37819165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Capturing and Chemiluminescent Sensing of Programmed Death Ligand-1 Expressing Extracellular Vesicles.
    Khan A; Di K; Khan H; He N; Li Z
    Biosensors (Basel); 2022 Apr; 12(5):. PubMed ID: 35624582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasensitive Single Extracellular Vesicle Detection Using High Throughput Droplet Digital Enzyme-Linked Immunosorbent Assay.
    Yang Z; Atiyas Y; Shen H; Siedlik MJ; Wu J; Beard K; Fonar G; Dolle JP; Smith DH; Eberwine JH; Meaney DF; Issadore DA
    Nano Lett; 2022 Jun; 22(11):4315-4324. PubMed ID: 35588529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrichment of circulating tumor-derived extracellular vesicles from human plasma.
    Yoh KE; Lowe CJ; Mahajan S; Suttmann R; Nguy T; Reichelt M; Yang J; Melendez R; Li Y; Molinero L; Ruppel J; Xu W; Plaks V
    J Immunol Methods; 2021 Mar; 490():112936. PubMed ID: 33242493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EV PD-L1 is Correlated With Clinical Features and Contributes to T Cell Suppression in Pediatric Thyroid Cancer.
    Wang G; He L; Wang S; Zhang M; Li Y; Liu Q; Sun N; Zhang X; Liu Y; Zhang J; Tai J; Ni X
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32459310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of T-cell-suppressive PD-L1
    Baur R; Karl F; Böttcher-Loschinski R; Stoll A; Völkl S; Gießl A; Flamann C; Bruns H; Schlötzer-Schrehardt U; Böttcher M; Schewe DM; Fischer T; Jitschin R; Mackensen A; Mougiakakos D
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36898735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-Recognition-Mediated Autocatalytic Amplification Assay for the Subpopulations of PD-L1 Positive Extracellular Vesicle.
    Ren Y; Ge K; Tang Q; Liang X; Fan L; Ye K; Wang M; Yao B
    Anal Chem; 2024 Jun; 96(23):9585-9592. PubMed ID: 38816678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles containing PD-L1 contribute to CD8+ T-cell immune suppression and predict poor outcomes in small cell lung cancer.
    Dou X; Hua Y; Chen Z; Chao F; Li M
    Clin Exp Immunol; 2022 May; 207(3):307-317. PubMed ID: 35553630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.
    Ricklefs FL; Alayo Q; Krenzlin H; Mahmoud AB; Speranza MC; Nakashima H; Hayes JL; Lee K; Balaj L; Passaro C; Rooj AK; Krasemann S; Carter BS; Chen CC; Steed T; Treiber J; Rodig S; Yang K; Nakano I; Lee H; Weissleder R; Breakefield XO; Godlewski J; Westphal M; Lamszus K; Freeman GJ; Bronisz A; Lawler SE; Chiocca EA
    Sci Adv; 2018 Mar; 4(3):eaar2766. PubMed ID: 29532035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicle-mediated immunoregulation in cancer.
    Yamamoto T; Yamamoto Y; Ochiya T
    Int J Hematol; 2023 May; 117(5):640-646. PubMed ID: 35951282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Microfluidic Device for Accurate Extracellular Vesicle Quantification and Protein Markers Analysis Directly from Human Whole Blood.
    Zhou S; Hu T; Zhang F; Tang D; Li D; Cao J; Wei W; Wu Y; Liu S
    Anal Chem; 2020 Jan; 92(1):1574-1581. PubMed ID: 31779307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages.
    Liu Y; Lu M; Chen J; Li S; Deng Y; Yang S; Ou Q; Li J; Gao P; Luo Z; Yuan P; Tan J; Gao X
    Sleep Breath; 2022 Jun; 26(2):893-906. PubMed ID: 34254261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Mesoporous Gold Sensor Unveils Phospho PD-L1 in Extracellular Vesicles as a Proxy for PD-L1 Expression in Lung Cancer Tissue.
    Shanmugasundaram KB; Ahmed E; Miao X; Kulasinghe A; Fletcher JA; Monkman J; Mainwaring P; Masud MK; Park H; Hossain MSA; Yamauchi Y; Sina AAI; O'Byrne K; Wuethrich A; Trau M
    ACS Sens; 2024 Jun; 9(6):3009-3016. PubMed ID: 38836608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated Fibroblast-derived Extracellular Vesicles Mediate Immune Escape of Bladder Cancer via PD-L1/PD-1 Expression.
    Feng R; Li Z; Ge G; Wang C; Jia Y; Ouyang J
    Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1410-1420. PubMed ID: 36852791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.
    Signorelli D; Ghidotti P; Proto C; Brambilla M; De Toma A; Ferrara R; Galli G; Ganzinelli M; Lo Russo G; Prelaj A; Occhipinti M; Viscardi G; Capizzuto V; Pontis F; Petraroia I; Ferretti AM; Colombo MP; Torri V; Sozzi G; Garassino MC; Jachetti E; Fortunato O
    Front Immunol; 2022; 13():987639. PubMed ID: 36203609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous detection of two subtypes of extracellular vesicles using ultrabright fluorescent nanosphere-based test strips.
    Li ZH; Liu XC; Wang D; Zhang ZL; Chen G; Yu ZL; Tian ZQ
    Anal Methods; 2024 Aug; 16(31):5403-5411. PubMed ID: 39036899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.
    Serratì S; Di Fonte R; Porcelli L; De Summa S; De Risi I; Fucci L; Ruggieri E; Marvulli TM; Strippoli S; Fasano R; Rafaschieri T; Guida G; Guida M; Azzariti A
    J Exp Clin Cancer Res; 2023 Sep; 42(1):251. PubMed ID: 37759291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC.
    Shukuya T; Ghai V; Amann JM; Okimoto T; Shilo K; Kim TK; Wang K; Carbone DP
    J Thorac Oncol; 2020 Nov; 15(11):1773-1781. PubMed ID: 32565389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.